激素不同给药途径预防内镜黏膜下剥离术后食管狭窄的研究进展
Research Progress on Prevention of Esophageal Stricture after Endoscopic Submucosal Dissection by Different Hormone Administration Routes
DOI: 10.12677/ACM.2022.121038, PDF,   
作者: 夏 抽:大理大学临床医学院,云南 大理;唐晓丹:云南省第一人民医院,云南 昆明
关键词: 食管癌内镜黏膜下剥离术狭窄预防激素Esophageal Cancer Endoscopic Submucosal Dissection Stricture Prevention Hormone
摘要: 内镜黏膜下剥离术(endoscopic submucosal dissection, ESD)是近年来治疗消化道早期癌及癌前病变的一项应用较为广泛的微创手术,由于ESD不仅可以获得需要明确诊断的病变的完整病理组织,还可以在不改变食管解剖结构的情况下对病变进行治愈性切除,还具有创伤小、恢复快、花费少等优势,目前已经成为早期食管癌的首选治疗手段。但大面积食管ESD术后易发生狭窄,影响患者生活质量。因此,如何预防术后狭窄是食管癌患者在ESD术后需要关注的重点。目前常用的预防方法包括口服或病灶局部使用糖皮质激素、内镜下球囊扩张(endoscopic balloon dilation, EBD)、聚乙醇酸网片使用以及支架植入等。如何选择适宜的治疗策略是目前研究的重点。激素在预防食管ESD术后狭窄方面具有重要作用,本文主要通过查阅近年来发表的文献分析比较激素不同给药方式预防食管ESD术后狭窄方面的优缺点。
Abstract: Endoscopic submucosal dissection (ESD) is a widely used minimally invasive surgery in the treatment of early and precancerous lesions of digestive tract in recent years. Meanwhile, ESD can not only obtain the complete pathological tissues of the lesions that need to be clearly diagnosed, but also obtain the endoscopic submucosal dissection (ESD). In addition, it can also be cured without changing the anatomical structure of the esophagus, and has the advantages of fewer traumas, quick recovery and less cost, so it has become the preferred treatment for early esophageal cancer. However, a large area of esophageal ESD surgery is prone to stenosis, which affects the quality of life of patients. Therefore, how to prevent postoperative stenosis is the focus of attention of esophageal cancer patients after ESD. At present, the commonly used prevention methods include oral or local use of glucocorticoids, endoscopic balloon dilation (EBD), polyglycolic acid mesh and stent implantation. How to choose the appropriate treatment strategy is the focus of current research. Hormone plays an important role in preventing esophageal ESD stenosis after surgery. This paper mainly analyzed and compared the advantages and disadvantages of different hormone administration methods in preventing esophageal ESD stenosis after surgery by referring to the literature published in recent years.
文章引用:夏抽, 唐晓丹. 激素不同给药途径预防内镜黏膜下剥离术后食管狭窄的研究进展[J]. 临床医学进展, 2022, 12(1): 252-258. https://doi.org/10.12677/ACM.2022.121038

参考文献

[1] 王海燕, 屈丽娜, 邓水苗, 等. 内镜黏膜下剥离术术后食管狭窄的预防新进展[J]. 兰州大学学报: 医学版, 2020, 46(3): 54-62.
[2] 魏宗苹, 姬瑞, 郑亚, 等. 食管癌行ESD术后预防狭窄治疗方法进展[J]. 胃肠病学和肝病学杂志, 2020, 29(12): 1411-1415.
[3] 聂丹, 黄永辉. 内镜黏膜下剥离术后食管狭窄的预防与治疗[J]. 中国微创外科杂志, 2018, 24(4): 333-337.
[4] Shi, Q., Ju, H., Yao, L.-Q., et al. (2014) Risk Factors for Postoperative Stricture after Endoscopic Submucosal Dissection for Superficial Esophageal Carcinoma. Endoscopy, 46, 640-644. [Google Scholar] [CrossRef] [PubMed]
[5] Jackson, C.R., Vijayasekaran, S. and Orford, J. (2009) Predictors of Postoperative Stricture after Esophageal Endoscopic Submucosal Dissection for Superficial Squamous Cell Neoplasms. Endoscopy, 41, 661-665. [Google Scholar] [CrossRef] [PubMed]
[6] Katada, C., Muto, M., Manabe, T., et al. (2003) Esophageal Stenosis after Endoscopic Mucosal Resection of Superficial Esophageal Lesions. Gastrointestinal Endoscopy, 57, 165-169. [Google Scholar] [CrossRef] [PubMed]
[7] Yamaguchi, N., Isomoto, H., Nakayama, T., et al. (2011) Usefulness of Oral Prednisolone in the Treatment of Esophageal Stricture after Endoscopic Submucosal Dissection for Superficial Esophageal Squamous Cell Carcinoma. Gastrointestinal Endoscopy, 73, 1115-1121. [Google Scholar] [CrossRef] [PubMed]
[8] 王华, 刘枫, 李兆申. 食管内镜黏膜下剥离术后狭窄的发生机制和预防[J]. 中华消化内镜杂志, 2015, 32(4): 266-269.
[9] 中华医学会消化内镜学分会消化内镜隧道技术协作组, 中国医师协会内镜医师分会, 北京医学会消化内镜学分会. 中国食管良恶性狭窄内镜下防治专家共识(2020, 北京) [J]. 中华消化内镜杂志, 2021, 38(3): 173-185.
[10] 范秀琴, 丁婷婷, 王雷. 食管1/2~3/4环周内镜黏膜下剥离术后食管狭窄的风险研究[J]. 中华消化内镜杂志, 2018, 35(2): 115-119.
[11] Kataoka, M., Anzai, S., Shirasaki, T., et al. (2015) Efficacy of Short Period, Low Dose Oral Prednisolone for the Prevention of Stricture after Circumferential Endoscopic Submucosal Dissection (ESD) for Esophageal Cancer. Endoscopy International Open, 3, E113-E117. [Google Scholar] [CrossRef] [PubMed]
[12] 樊怡茹, 孙淑珍, 王红建. 小剂量长周期泼尼松对食管内镜黏膜下剥离术后食管狭窄的预防作用[J]. 河南医学研究, 2020, 29(26): 4823-4826.
[13] Nagami, Y., Shiba, M., Tominaga, K., et al. (2016) Locoregional Steroid Injection Prevents Stricture Formation after Endoscopic Submucosal Dissection for Esophageal Cancer: A Propensity Score Matching Analysis. Surgical Endoscopy, 30, 1441-1449. [Google Scholar] [CrossRef] [PubMed]
[14] Ishihara, R. (2019) Prevention of Esophageal Stricture after Endoscopic Resection. Digestive Endoscopy, 31, 134-145. [Google Scholar] [CrossRef] [PubMed]
[15] Hashimoto, S., Kobayashi, M., Takeuchi, M., et al. (2011) The Efficacy of Endoscopic Triamcinolone Injection for the Prevention of Esophageal Stricture after Endoscopic Submucosal Dissection. Gastrointestinal Endoscopy, 74, 1389-1393. [Google Scholar] [CrossRef] [PubMed]
[16] Werner, S. and Grose, R. (2003) Regulation of Wound Healing by Growth Factors and Cytokines. Physiological Reviews, 83, 835-870. [Google Scholar] [CrossRef] [PubMed]
[17] Hanaoka, N., Ishihara, R., Takeuchi, T., et al. (2012) Intralesional Steroid Injection to Prevent Stricture after Endoscopic Submucosal Dissection for Esophageal Cancer: A Controlled Prospective Study. Endoscopy, 44, 1007-1011. [Google Scholar] [CrossRef] [PubMed]
[18] Tsujii, Y., Nishida, T., Nishiyama, O., et al. (2015) Clinical Outcomes of Endoscopic Submucosal Dissection for Superficial Esophageal Neoplasms: A Multicenter Retrospective Cohort Study. Endoscopy, 47, 775-783. [Google Scholar] [CrossRef] [PubMed]
[19] 邱钰, 冯亚东, 杨超虎, 等. 糖皮质激素预防食管内镜黏膜下剥离术后狭窄的临床观察[J]. 中华消化内镜杂志, 2021, 38(2): 143-148.
[20] Chu, Y., Chen, T., et al. (2019) Long-Term Efficacy and Safety of Intralesional Steroid Injection plus Oral Steroid Administration in Preventing Stricture after Endoscopic Submucosal Dissection for Esophageal Epithelial Neoplasms. Surgical Endoscopy, 33, 1244-1251. [Google Scholar] [CrossRef] [PubMed]
[21] Mori, H., Rafiq, K., Kobara, H., et al. (2013) Steroid Permeation into the Artificial Ulcer by Combined Steroid Gel Application and Balloon Dilatation: Prevention of Esophageal Stricture. Journal of Gastroenterology & Hepatology, 28, 999-1003. [Google Scholar] [CrossRef] [PubMed]
[22] Shibagaki, K., Ishimura, N., Oshima, N., et al. (2018) Esophageal Triamcinolone Acetonide-Filling Method: A Novel Procedure to Prevent Stenosis after Extensive Esophageal Endoscopic Submucosal Dissection (with Videos). Gastrointestinal Endoscopy, 87, 380-389. [Google Scholar] [CrossRef] [PubMed]
[23] 阮荣蔚. 内镜黏膜下剥离术后食管狭窄预防的研究进展[J]. 临床荟萃, 2019, 34(5): 458-462.
[24] Kato, R., Yamasaki, Y. and Tanaka, S. (2018) Triamcinolone Injection and Filling Method to Prevent Stricture after Esophageal Endoscopic Submucosal Dissection. Digestive Endoscopy, 30, 795-796. [Google Scholar] [CrossRef] [PubMed]
[25] Jalali, M. and Bayat, A. (2007) Current Use of Steroids in Management of Abnormal Raised Skin Scars. Surgeon, 5, 175-180. [Google Scholar] [CrossRef
[26] Oliveira, J.F., Moura, E., Bernardo, W.M., et al. (2016) Prevention of Esophageal Stricture after Endoscopic Submucosal Dissection: A Systematic Review and Meta-Analysis. Surgical Endoscopy, 39, 2779-2791.
[27] 李贞娟, 柴宁莉, 令狐恩强, 等. 激素预防食管早癌内镜黏膜下剥离术后食管狭窄效果的Meta分析[J]. 中华胃肠内镜电子杂志, 2018, 5(1): 18-28.
[28] Choudari, C.P., Rajgopal, C. and Palmer, K.R. (1994) Acute Gastrointestinal Haemorrhage in Anticoagulated Patients: Diagnoses and Response to Endoscopic Treatment. Gut, 35, 464-466. [Google Scholar] [CrossRef] [PubMed]
[29] Antithrombotic Trialists’ Collaboration (2002) Collaborative Meta-Analysis of Randomised Trials of Antiplatelet Therapy for Prevention of Death, Myocardial Infarction, and Stroke in High Risk Patients. BMJ, 324, 71-86.